Arcellx, Inc.
ACLXDelisted Apr 28, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001786205
Arcellx, Inc. was delisted on Apr 28, 2026; its insiders filed their last Form 4 on Apr 28, 2026; 240 institutions reported holding it in 13F filings for Q1 2026, worth $6.52B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Arcellx, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 117 | 138 | +21 |
| Shares | 45.6M | 48.1M | +2.48M (+5.4%) |
| Value | $1.40B | $1.52B | +$116.2M (+8.3%) |
New holders (32)
Institutions that held Arcellx, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (11)
Institutions that held Arcellx, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Braidwell LP | 333,800 | $10.3M |
| Altium Capital Management LP | 150,000 | $4.62M |
| Caas Capital Management LP | 124,959 | $3.85M |
| Kynam Capital Management, LP | 31,336 | $965.5K |
| Vident Investment Advisory, LLC | 22,755 | $701.1K |
| Fred Alger Management, LLC | 14,374 | $442.9K |
| Verition Fund Management LLC | 12,345 | $380.3K |
| SG Americas Securities, LLC | 11,962 | $369.0K |
| Point72 Asset Management, L.P. | 11,641 | $358.6K |
| MYDA Advisors LLC | 8,000 | $246.5K |
| TCI Wealth Advisors, Inc. | 118 | $3.64K |